is a biotechnology company that specializes in the development of cellular therapies for the treatment of diseases and conditions that impact tens of millions of people worldwide. The company applies stem cell-based technologies (both adult and human embryonic) and other proprietary methods in the field of regenerative medicine to bring patient-specific therapies from the lab bench to the bedside.
01/09/2013 - Chairman's Blog
2013: The Year Regenerative Medicine Hits Its Stride
09/20/2012 - Chairman's Blog
Reflecting on Today's Announcement: Our Best Financing Deal Ever
May 9, 2013, 04:30 PM EDT
Conference Call: 2013 Q1 Results and Corporate Update
Click here for webcast
April 17, 2013, 03:45 PM EDT
ARM’s Regen Med Investor Day, New York, NY
March 12, 2013, 11:00 AM EDT
BIO-Europe, Barcelona, Spain
Click here for presentation (PDF)
Advanced Cell Technology Announces 2013 First Quarter Results
ARM’s Regen Med Investor Day, New York City, April 17, 2013 (PDF)
BIO-Europe, Barcelona, Spain, March 12, 2013 (PDF)
BIO CEO & Investor Conference, New York City, February 11, 2013 (PDF)
Click here for our company profile (PDF)
2013 Smart Guide: Revolutionary Human Stem Cell Trial - New Scientist
Stem Cell Trial Without Embryo Destruction - Wall Street Journal